USANA Health Sciences, Inc. USNA
NYSE
| 10/03/2026 | 07/04/2026 | 04/04/2026 | 01/03/2026 | 09/27/2025 | |
|---|---|---|---|---|---|
| Net Income | -21.20M | -22.16M | 8.87M | 10.76M | 16.99M |
| Total Depreciation and Amortization | 38.91M | 38.81M | 39.25M | 39.70M | 35.30M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 38.65M | 40.94M | 15.95M | 14.97M | 9.64M |
| Change in Net Operating Assets | -14.71M | -29.86M | -47.44M | -43.08M | -30.41M |
| Cash from Operations | 41.65M | 27.73M | 16.63M | 22.35M | 31.52M |
| Capital Expenditure | -12.12M | -11.79M | -13.67M | -13.82M | -12.83M |
| Sale of Property, Plant, and Equipment | 3.97M | 3.97M | 3.95M | 3.91M | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -203.34M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -917.00K | -917.00K | 865.00K | -207.00K | -207.00K |
| Cash from Investing | -9.06M | -8.74M | -8.85M | -10.13M | -216.37M |
| Total Debt Issued | 25.00M | 25.00M | 21.60M | 17.60M | 24.60M |
| Total Debt Repaid | -25.00M | -25.00M | -30.60M | -26.60M | -24.59M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -2.44M | -2.45M | -17.65M | -29.85M | -29.87M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.87M | -2.75M | -3.13M | -1.75M | -1.26M |
| Cash from Financing | -4.31M | -5.19M | -29.78M | -40.60M | -31.13M |
| Foreign Exchange rate Adjustments | 5.46M | 3.59M | 5.29M | 5.11M | -3.61M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 33.74M | 17.38M | -16.71M | -23.27M | -219.59M |